Jin Wang
University of North Carolina at Chapel Hill(US)Weifang Medical University(CN)Beijing Institute of Technology(CN)Beijing Tongren Hospital(CN)Shandong University of Traditional Chinese Medicine(CN)Guangdong University of Technology(CN)Jilin Normal University(CN)Sun Yat-sen University(CN)Hunan Normal University(CN)University of Tennessee at Chattanooga(US)Shanxi Medical University(CN)Baylor College of Medicine(US)Shanghai Jiao Tong University(CN)Capital Medical University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Beijing Jiaotong University(CN)Sichuan University(CN)Fudan University(CN)Kunming Medical University(CN)China Tobacco(CN)Ruijin Hospital(CN)Sir Run Run Shaw Hospital(CN)Hefei Institutes of Physical Science(CN)Chinese PLA General Hospital(CN)Changsha Normal University(CN)West China Hospital of Sichuan University(CN)Zhejiang Cancer Hospital(CN)Jilin Engineering Normal University(CN)Tongren Hospital(CN)Beijing Institute of Neurosurgery(CN)First Affiliated Hospital of Xinxiang Medical University(CN)Hunan Cancer Hospital(CN)Beijing National Laboratory for Molecular Sciences(CN)First Affiliated Hospital of Kunming Medical University(CN)Luohe Medical College(CN)Beijing Municipal Ecological and Environmental Monitoring Center(CN)Peking University First Hospital(CN)Wuhan Third Hospital(CN)Science and Technology on Surface Physics and Chemistry Laboratory(CN)Yancheng Teachers University(CN)NewGen Therapeutics (United States)(US)Sun Yat-sen University Cancer Center(CN)Shanghai Institute of Hematology(CN)Beijing Ditan Hospital(CN)Business Innovation Center (Bulgaria)(BG)Shandong Maternal and Child Health Hospital(CN)Shandong First Medical University(CN)Beijing Advanced Sciences and Innovation Center(CN)Xinxiang Medical University(CN)Auburn University(US)Chongqing Medical University(CN)McMaster University(CA)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, RNA Interference and Gene Delivery, Chemical Reactions and Mechanisms, Lung Cancer Treatments and Mutations, Ubiquitin and proteasome pathways
Most-Cited Works
- → Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study(2020)545 cited
- → More Effective Nanomedicines through Particle Design(2011)478 cited
- → Microbial Genetic Composition Tunes Host Longevity(2017)346 cited
- → The Complex Role of Multivalency in Nanoparticles Targeting the Transferrin Receptor for Cancer Therapies(2010)331 cited
- → Quantitative real-time imaging of glutathione(2017)267 cited
- → CD73 alleviates GSDMD‐mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling(2020)235 cited